The Proteomics of Colorectal Cancer: Identification of a Protein Signature Associated with Prognosis

被引:73
|
作者
O'Dwyer, Donna [1 ]
Ralton, Lynda D. [1 ]
O'Shea, Aisling [1 ]
Murray, Graeme I. [1 ]
机构
[1] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland
来源
PLOS ONE | 2011年 / 6卷 / 11期
基金
英国生物技术与生命科学研究理事会;
关键词
POOR-PROGNOSIS; EXPRESSION; MARKERS; BIOMARKERS; THERAPY; HSP60; CYTOCHROME-P450; PREDICTION; ANNEXINS; GROWTH;
D O I
10.1371/journal.pone.0027718
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Colorectal cancer is one of the commonest types of cancer and there is requirement for the identification of prognostic biomarkers. In this study protein expression profiles have been established for colorectal cancer and normal colonic mucosa by proteomics using a combination of two dimensional gel electrophoresis with fresh frozen sections of paired Dukes B colorectal cancer and normal colorectal mucosa (n = 28), gel image analysis and high performance liquid chromatography-tandem mass spectrometry. Hierarchical cluster analysis and principal components analysis showed that the protein expression profiles of colorectal cancer and normal colonic mucosa clustered into distinct patterns of protein expression. Forty-five proteins were identified as showing at least 1.5 times increased expression in colorectal cancer and the identity of these proteins was confirmed by liquid chromatography-tandem mass spectrometry. Fifteen proteins that showed increased expression were validated by immunohistochemistry using a well characterised colorectal cancer tissue microarray containing 515 primary colorectal cancer, 224 lymph node metastasis and 50 normal colonic mucosal samples. The proteins that showed the greatest degree of overexpression in primary colorectal cancer compared with normal colonic mucosa were heat shock protein 60 (p < 0.001), S100A9 (p < 0.001) and translationally controlled tumour protein (p, 0.001). Analysis of proteins individually identified 14-3-3 beta as a prognostic biomarker (chi(2) = 6.218, p = 0.013, HR = 0.639, 95% CL 0.448-0.913). Hierarchical cluster analysis identified distinct phenotypes associated with survival and a two-protein signature consisting of 14-3-3b and aldehyde dehydrogenase 1 was identified as showing prognostic significance (chi(2) = 7.306, p = 0.007, HR = 0.504, 95% CL 0.303-0.838) and that remained independently prognostic (p = 0.01, HR = 0.416, 95% CL 0.208-0.829) in a multivariate model.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Identification of glutamine metabolism-related gene signature to predict colorectal cancer prognosis
    Xie, Yang
    Li, Jun
    Tao, Qing
    Wu, Yonghui
    Liu, Zide
    Zeng, Chunyan
    Chen, Youxiang
    JOURNAL OF CANCER, 2024, 15 (10): : 3199 - 3214
  • [2] A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer
    Li, Xueping
    Zhang, Qiang
    Zhao, Lan
    Jiang, Longyang
    Qi, Aoshuang
    Wei, Qian
    Song, Xinyue
    Wang, Lin
    Zhang, Liwen
    Zhao, Yanyun
    Lv, Xuemei
    Wei, Minjie
    Zhao, Lin
    JOURNAL OF CANCER, 2020, 11 (08): : 2139 - 2149
  • [3] A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer
    Zhang, Cong
    Zeng, Cailing
    Xiong, Shaoquan
    Zhao, Zewei
    Wu, Guoyu
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [4] Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer
    Wu, Yucai
    Liu, Yi
    He, Anbang
    Guan, Bao
    He, Shiming
    Zhang, Cuijian
    Kang, Zhengjun
    Gong, Yanqing
    Li, Xuesong
    Zhou, Liqun
    FRONTIERS IN GENETICS, 2020, 11
  • [5] Identification of a novel immune signature for optimizing prognosis and treatment prediction in colorectal cancer
    Li, Yan
    Li, Yiyi
    Xia, Zijin
    Zhang, Dun
    Chen, Xiaomei
    Wang, Xinyu
    Liao, Jing
    Yi, Wei
    Chen, Jun
    AGING-US, 2021, 13 (23): : 25518 - 25549
  • [6] A Targeted Proteomics Approach Reveals a Serum Protein Signature as a Diagnostic Biomarker for Colorectal Cancer
    Wan, Yu
    Luo, Wenfeng
    Song, Xiaoyu
    Zhao, Ying
    Han, Zeping
    Shen, Jian
    Xie, Fangmei
    Li, Yuguang
    He, Jinhua
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 10755 - 10768
  • [7] Identification of a prognosis-associated signature associated with energy metabolism in triple-negative breast cancer
    Li, Chao
    Li, Xujun
    Li, Guangming
    Sun, Long
    Zhang, Wei
    Jiang, Jing
    Ge, Qidong
    ONCOLOGY REPORTS, 2020, 44 (03) : 819 - 837
  • [8] A Five-gene Signature for Predicting the Prognosis of Colorectal Cancer
    Hong, Junfeng
    Lin, Xiangwu
    Hu, Xinyu
    Wu, Xiaolong
    Fang, Wenzheng
    CURRENT GENE THERAPY, 2021, 21 (04) : 280 - 289
  • [9] Gene dysregulation analysis builds a mechanistic signature for prognosis and therapeutic benefit in colorectal cancer
    Li, Quanxue
    Dai, Wentao
    Liu, Jixiang
    Sang, Qingqing
    Li, Yi-Xue
    Li, Yuan-Yuan
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2020, 12 (11) : 881 - 893
  • [10] Identification of 6 Hub Proteins and Protein Risk Signature of Colorectal Cancer
    Yue, Taohua
    Liu, Cheng
    Zhu, Jing
    Huang, Zhihao
    Guo, Shihao
    Zhang, Yuyang
    Xu, Hao
    Liu, Yucun
    Wang, Pengyuan
    Chen, Shanwen
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020